Lack of delayed neurocognitive side effects of Gamma Knife radiosurgery in acromegaly: the Later-Ac study.
Acromegaly
/ epidemiology
Adenoma
/ complications
Adult
Aged
Cancer Survivors
/ statistics & numerical data
Case-Control Studies
Cross-Sectional Studies
Female
France
/ epidemiology
Gamma Rays
/ adverse effects
Growth Hormone-Secreting Pituitary Adenoma
/ complications
Humans
Male
Middle Aged
Neurocognitive Disorders
/ epidemiology
Neuropsychological Tests
Radiation Injuries
/ epidemiology
Radiosurgery
/ adverse effects
Treatment Outcome
Journal
European journal of endocrinology
ISSN: 1479-683X
Titre abrégé: Eur J Endocrinol
Pays: England
ID NLM: 9423848
Informations de publication
Date de publication:
30 Nov 2021
30 Nov 2021
Historique:
received:
12
08
2021
accepted:
28
10
2021
pubmed:
30
10
2021
medline:
15
12
2021
entrez:
29
10
2021
Statut:
epublish
Résumé
Persistent growth hormone hypersecretion can be observed in roughly 50% of patients operated for somatotroph adenomas, requiring additional treatments. Despite its proven antisecretory efficacy, the use of Gamma Knife radiosurgery (GK) is limited probably due to the lack of data on long-term side effects, including potential cognitive consequences. The LATe Effects of Radiosurgery in Acromegaly study was a cross-sectional exposed/unexposed non-randomized study. The primary objective was to determine the long-term neurocognitive effects of GK focusing on memory, executive functions, and calculation ability. Exposed patients had been treated by GK for acromegaly at least 5 years before inclusion. Unexposed patients (paired for age) had to be cured or controlled at last follow-up without any radiation technique. Patients of both groups were cured or controlled at the last follow-up. Sixty-four patients were evaluated (27 exposed and 37 unexposed). Mean follow-up after GK was 13 ± 6 years (including 24 patients followed for at least 10 years). While up to 23.8% of the patients of the whole cohort presented at least one abnormal cognitive test, we did not observe any significant difference in neurocognitive function between both groups. During the follow-up, 11 patients presented at least one new pituitary deficiency (P = 0.009 for thyroid-stimulating hormone deficiency with a higher rate in exposed patients), two presented a stroke (1 in each group), and one presented a meningioma (12 years after GK). While GK exposes patients to a well-known risk of pituitary deficiency, it does not seem to induce long-term cognitive consequences in patients treated for acromegaly.
Identifiants
pubmed: 34714763
doi: 10.1530/EJE-21-0826
pii: EJE-21-0826
doi:
pii:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM